| Williston Basin Eyecare Associates, P.c. | |
|
1213 15th Ave W, Williston, ND 58801-3800 | |
| (701) 577-3937 | |
| Not Available |
| Full Name | Williston Basin Eyecare Associates, P.c. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1213 15th Ave W, Williston, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225323504 | NPI | - | NPPES |
| Provider Name | Mitchell R Fearing |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1447347547 PECOS PAC ID: 5991844128 Enrollment ID: I20091202000114 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Provider Name | Michael D Tofte |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437223815 PECOS PAC ID: 2163561390 Enrollment ID: I20091202000136 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Provider Name | Laurali M Sime |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1851465223 PECOS PAC ID: 1456490697 Enrollment ID: I20091202000213 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Provider Name | Danielle J Brenno Watterud |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205924636 PECOS PAC ID: 4880733922 Enrollment ID: I20091202000242 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Provider Name | Allison R Anderson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1336478924 PECOS PAC ID: 4284776634 Enrollment ID: I20100122000382 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Provider Name | Julieann C Wick |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1235156753 PECOS PAC ID: 3173551389 Enrollment ID: I20141218000038 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Provider Name | Rebecca Rasmussen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1306171483 PECOS PAC ID: 0648429159 Enrollment ID: I20191216000427 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Williston Basin Eyecare Associates, P.c. 1213 15th Ave W, Williston, ND 58801-3800 Ph: (701) 577-3937 | Williston Basin Eyecare Associates, P.c. 1213 15th Ave W, Williston, ND 58801-3800 Ph: (701) 577-3937 |
News Archive
Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and The Pink Sheet, today announced the agenda for Windhover's 2nd PharmAsia Summit (Oct. 25-26). This year's Summit will bring top biopharma leaders from Asia and the U.S. to San Francisco to share what works and what doesn't in China, India, Japan and the Pacific Rim.
Patients with Parkinson's disease who undergo deep brain stimulation (DBS)—a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain—can expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology.
ViLim Ball technology created at a Lithuanian startup company Fidens helps to reduce uncontrollable shaking hands, which is one of the symptoms of essential tremor. The technology is effective in 7 out of 10 cases, and it can also be used to alleviate morning stiffness of joints for rheumatoid arthritis sufferers.
Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.
Bioniche Life Sciences In., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
› Verified 6 days ago
Danielle J Brenno-watterud, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1213 15th Ave W, Williston, ND 58801 Phone: 701-577-3937 Fax: 701-577-3938 | |
Dr. Julieann Carol Wick, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1321 W Dakota Pkwy, Williston, ND 58801 Phone: 701-572-7641 Fax: 701-572-7710 | |
Dakota Eye Care, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4001 2nd Ave W, Williston, ND 58801 Phone: 701-577-2020 Fax: 701-577-2021 | |
Dr. Rebecca Rasmussen, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1500 14th St W Ste 100, Williston, ND 58801 Phone: 701-577-3937 | |
Allison R Anderson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1213 15th Ave W, Williston, ND 58801 Phone: 701-577-3937 Fax: 701-577-3938 | |
Michael Tofte, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1213 15th Ave W, Williston, ND 58801 Phone: 701-577-3937 Fax: 701-577-3938 |